Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Marco Borderi"'
Autor:
Antonella Cingolani, Giordano Madeddu, Silvia Nozza, Stefano Rusconi, Renato Maserati, Alessandra Bandera, Paolo Maggi, Giulia Marchetti, Miriam Lichtner, Andrea Calcagno, Maurizio Zazzi, Nicola Gianotti, Sergio Lo Caputo, Marco Borderi, Anna Maria Cattelan, Antonio Di Biagio, Franco Maggiolo, Stefano Bonora
Publikováno v:
Expert Review of Anti-infective Therapy. 19:443-456
Introduction Antiretroviral therapy (ART) is the most significant advance in the medical management of HIV-1 infection. Given the fact that HIV cannot be eradicated from the body, ART has to be indefinitely maintained. New approaches need to be defin
Autor:
Fabio Esposito, Maria Carla Re, Giacomo Beci, Marco Borderi, Vincenzo Colangeli, Isabella Bon, Pierluigi Viale, Leonardo Calza
Publikováno v:
Infectious Diseases. 53:81-88
Objectives: Metabolic syndrome (MetS) is usually associated in general population with systemic inflammation and higher cardiovascular risk, but data about the effect of statins in patients with HIV infection and MetS are lacking to date. Methods: Pr
Autor:
Simona Coladonato, Aurora Borioni, Pierluigi Viale, Bianca Granozzi, Marco Borderi, Leonardo Calza, Vincenzo Colangeli
Publikováno v:
Infectious Diseases. 52:249-256
Objectives: Cardiovascular disease has become one of the most common comorbidities among HIV-infected patients, but available data about the correlation between antiretroviral drugs and progression rate of atherosclerotic disease are still limited. W
Autor:
Bruno Cacopardo, M. A. Ursitti, Claudio Maria Mastroianni, Emanuele Nicastri, R. Piolini, A. Antinori, Giustino Parruti, S. Truffa, Ivan Gentile, Giovanni Cassola, E. Girardi, I. Caramma, Andrea Calcagno, Laura Monno, A d'Arminio Monforte, R. Acinapura, Francesca Ceccherini-Silberstein, A. Di Biagio, Gabriella Verucchi, Alessandra Latini, Simone Marcotullio, Nicola Gianotti, C. Balotta, Camilla Tincati, M. C. Moioli, Alessandro Tavelli, Pietro Caramello, Carmen Rita Santoro, C. Abeli, A. Londero, F. Di Martino, R. Iardino, Stefano Bonora, M. Andreoni, A. Costantini, Raffaella Libertone, F. von Schloesser, G. Prota, Annalisa Saracino, Maria Grazia Cecchetto, Antonio Cristaudo, Mauro Zaccarelli, Carmela Pinnetti, Fabrizio Carletti, N. Abrescia, Andrea Giacometti, L. Gallo, Paolo Bonfanti, G. Angarano, E. Quiros Roldan, G. Pellizzer, F. Petrone, Giovanni Mazzarello, Silvia Nozza, R. Orlando, Franco Baldelli, Giovanni Guaraldi, Paola Meraviglia, Laura Sighinolfi, S. Carrara, D. Segala, Giuliano Rizzardini, C. Suardi, P. Piano, Mauro Sciandra, Daniela Francisci, A. De Luca, Patrizia Lorenzini, Paola Cinque, Tiziana Quirino, S. Graziano, Cristina Mussini, Massimo Galli, Giuseppe Ippolito, S. Lo Caputo, Benedetto Maurizio Celesia, C. Valeriani, Matteo Bassetti, Maria Rosaria Capobianchi, Claudio Viscoli, Vinicio Manfrin, Alessandro Chiodera, Alessandra Bandera, Guglielmo Borgia, Cinzia Puzzolante, Stefano Rusconi, Leonardo Calza, Valeria Belvisi, Francesca Vichi, Serena Quartu, Roberto Cauda, J. Vecchiet, Antonio Chirianni, A. Di Caro, P.E. Manconi, Stefania Cicalini, G. Magnani, M. Lichtner, Milensu Shanyinde, Stefano Savinelli, M. Puoti, Giulia Marchetti, Laura Carenzi, Carlo Federico Perno, Annalisa Ridolfo, G. Di Perri, F. Maggiolo, A Castagna, G. Orofino, Roberto Rossotti, Francesco Mazzotta, Gianmaria Baldin, Giovanni Lapadula, A. Rodano, V. Donati, Barbara Rossetti, F. Viviani, Adriana Ammassari, N. Bobbio, Adriano Lazzarin, C. Minardi, A. Alessandrini, Katia Falasca, Maria Stella Mura, Tamara Ursini, Andrea Gori, A. Cingolani, L. Maddaloni, Alessandro Cozzi-Lepri, Francesco Castelli, Iuri Fanti, Giordano Madeddu, E. Quiros, P. Viale, Marco Borderi, M. Capozzi, Vincenzo Vullo
Publikováno v:
Journal of Antimicrobial Chemotherapy. 74:2732-2741
ObjectivesOur aim was to investigate the durability of different initial regimens in patients starting ART with CD4+ counts 5 log10 copies/mL.MethodsThis was a retrospective study of HIV-infected patients prospectively followed in the ICONA cohort. T
Autor:
Leonardo Calza, Vincenzo Colangeli, Paolo Gaibani, Pierluigi Viale, Isabella Bon, Gabriella Verucchi, Marco Borderi, Luciano Attard, Caterina Vocale, Lorenzo Badia, Marina Tadolini, Giada Rossini
Publikováno v:
Infection
Background Since the end of February 2020, the Coronavirus Disease 2019 (COVID-19) outbreak rapidly spread throughout Italy and other European countries, but limited information has been available about its characteristics in HIV-infected patients. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33d4dc23fa2607e4818e59eecc690c3b
http://hdl.handle.net/11585/864516
http://hdl.handle.net/11585/864516
Autor:
Maria Carla Re, Leonardo Calza, Marco Borderi, Aurora Borioni, Francesca Volpato, Isabella Bon, Vincenzo Colangeli, Pierluigi Viale
Background: Weight gain after initiation of combination antiretroviral therapy (cART) is a possible side effect of all antiretroviral regimens, but it seems to be more evident in association with integrase strand transfer inhibitors (INSTIs). So, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47e800abee6fd76bbc01e79d79a99864
http://hdl.handle.net/11585/740321
http://hdl.handle.net/11585/740321
Autor:
Pierluigi Viale, Maria Carla Re, Vincenzo Colangeli, Marco Borderi, Isabella Bon, Leonardo Calza, Bianca Granozzi, Diletta Testi
Publikováno v:
The Journal of antimicrobial chemotherapy. 75(11)
Background Antiretroviral dual regimens including lamivudine and one boosted PI or dolutegravir are warranted in order to optimize combination ART (cART), prevent long-term toxicity and reduce the cost of treatments. Objectives We hypothesized that a
Autor:
Marco Borderi, Maria Carla Re, Simona Coladonato, Leonardo Calza, Isabella Bon, Vincenzo Colangeli, Pierluigi Viale, Beatrice Tazza
OBJECTIVES An observational, prospective, cohort study was performed to assess changes in insulin sensitivity and serum leptin level after a switch from a ritonavir-boosted PI (PI/r) to raltegravir or dolutegravir in HIV-infected adults on stable com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0380a6496789465a0b629c9f5e6b2320
http://hdl.handle.net/11585/662532
http://hdl.handle.net/11585/662532
Autor:
Simona Coladonato, Giacomo Fornaro, Beatrice Tazza, Marco Borderi, Gabriella Verucchi, Leonardo Calza, Vincenzo Colangeli, Viola Guardigni, Lorenzo Badia, Pierluigi Viale
Background: The ritonavir-boosted protease inhibitor (PI/r) use has been associated with several metabolic abnormalities, and the non-alcoholic fatty liver disease (NAFLD) is becoming a very frequent comorbidity among HIV-infected patients. Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4589bc8bf6b6af2c118a42fa124f9a4
http://hdl.handle.net/11585/693732
http://hdl.handle.net/11585/693732
Autor:
Matteo Cafaggi, Massimiliano Lanzafame, Marco Borderi, Maria Carla Re, Enrico Barchi, Leonardo Calza, Anna Degli Antoni, Isabella Bon, Vincenzo Colangeli, Stefano Nicolè, Pierluigi Viale
Publikováno v:
Infectious diseases (London, England). 50(5)
Background: The ritonavir-boosted protease inhibitor (PI/r)-based dual regimens are warranted in order to optimize the combination antiretroviral therapy (cART), prevent the long-term toxicity and reduce the cost of treatments. Methods: We performed